Trillium Therapeutics
Latest round
- Series C
Last raised
- Sep 2008
Total raised
- $11M
Investors
- 3
About Trillium Therapeutics
Founded in 2004 and headquartered in Mississauga, Canada, Trillium Therapeutics Inc. focuses on the development of therapies for cancer.Trillium Therapeutics Inc. is dedicated to advancing immuno-oncology treatments, working on innovative products designed to enhance patient outcomes in cancer care. The company's pipeline includes therapies that leverage the body’s immune system to fight cancer effectively.Trillium Therapeutics Inc. generates revenue through the development and potential commercialization of its immuno-oncology therapies. secured CAD 2 million, the company plans to allocate these resources toward the development and clinical trials of its immuno-oncology products. The firm aims to expand its reach into new markets, with a focus on North America and Europe, to enhance the availability of its innovative therapies for cancer patients.
Who invested in Trillium Therapeutics
3 investors across 1 round
See all investors in Trillium Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Sep 17, 2008
Amount
$11M
Investors
Questions about Trillium Therapeutics
Who invested in Trillium Therapeutics?
Trillium Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Trillium Therapeutics raised?
Trillium Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Trillium Therapeutics last raise money?
Trillium Therapeutics's most recent round on record is a Series C, in Sep 2008.
What does Trillium Therapeutics do?
Founded in 2004 and headquartered in Mississauga, Canada, Trillium Therapeutics Inc.
Where is Trillium Therapeutics headquartered?
Trillium Therapeutics is headquartered in Mississauga, Canada.
Which VCs invest in companies like Trillium Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Trillium Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Trillium Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.